Cancer Biology & Medicine

 


Cancer Biology & Medicine

Cancer Biology & Medicine is a peer-reviewed open-access journal published by the Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. Published quarterly, the journal provides innovative andsignificant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics:

● Cancer genetics

● Cancer and stem cell biology

● Molecular and clinical immunology

● Cancer prevention and epidemiology

● Cancer biomarkers

● Radiation oncology

● Oncology clinical trials

● Mechanisms of drug sensitivity and resistance

● Targeted therapy and immunotherapy

● Multidisciplinary treatment and personalized medicine

Author Benefits

● Easy submission via online system

● Efficient and professional peer review

● Rapid pre-print online publication

● No charge for publication and open access

● International visibility-All full texts are free in PubMed Central

 

Announcements

 

Call for Papers on Liver Cancer Research and Treatment

 

Cancer Biology & Medicine will publish a special issue on December 30th, 2016 to report the advances in liver cancer research and treatment. Perspectives, editorials, reviews, original articles, case reports or meeting reports are all welcomed. The deadline for submission is August 30th.

 

There will be no charge for publication and open access. All full texts will be archived in PubMed Central and the special issue will be promoted in various cancer meetings.

 

Online submission website: https://mc03.manuscriptcentral.com/cbm

Official website: www.cancerbiomed.org

E-mail: editor@cancerbiomed.org

 
Posted: 2016-05-24
 

Call for paper on Cancer Nanomedicine

 

Following the success of “Cancer Nanomedicine” special issue in 2015, Cancer Biology & Medicine is organizing another special issue on this theme to display the state-of-the-art research results of this field and promote the academic exchange among related scholars. The special issue will be published on September 30th, and the submission deadline is July 5th.

 

As the official journal of Chinese Anti-Cancer Association (CACA), Cancer Biology & Medicine is now indexed in PubMed Central and all full texts are available as open access (http://www.ncbi.nlm.nih.gov/pmc/journals/2000/).

 

We warmly welcome you to contribute articles to this special issue. Perspective, editorial, review, mini review, original article, and case report / meeting report are all welcomed. Here is the link to online submission system: https://mc03.manuscriptcentral.com/cbm. There will be no charge for publication and open access. All full texts will be archived in PubMed Central and the special issue will be promoted in various cancer meetings.

Xi-Shan Hao, M.D., Professor

Editor-in-Chief, Cancer Biology & Medicine,

President, Chinese Anti-Cancer Association,

Member, Board of Director, Union for International Cancer Control (UICC)

 
Posted: 2016-04-21
 
More Announcements...

Vol 13, No 1: March 2016 (Special Issue on Genome Sequencing and Precision Cancer Treatment)

Table of Contents

Editorial

The next generation of cancer management PDF
Wayne W. Grody 1-2

Review

Current practices and guidelines for clinical next-generation sequencing oncology testing PDF
Samuel P. Strom 3-11
Changing paradigm of cancer therapy: precision medicine by next-generation sequencing PDF
Yuan Xue, William R. Wilcox 12-18
The potential for liquid biopsies in the precision medical treatment of breast cancer PDF
Victoria A. Forte, Dany K. Barrak, Mostafa Elhodaky, Lily Tung, Anson Snow, Julie E. Lang 19-40
Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification PDF
Rina Kansal 41-54
Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing PDF
Christine Stanislaw, Yuan Xue, William R. Wilcox 55-67
Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options PDF
Arpita Desai, Smitha P. Menon, Grace K. Dy 77-86
Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma PDF
Megan L. Ludwig, Andrew C. Birkeland, Rebecca Hoesli, Paul Swiecicki, Matthew E. Spector, J. Chad Brenner 87-100
Evolving role of adiponectin in cancercontroversies and update PDF
Arnav Katira, Peng H. Tan 101-119
Colorectal cancer carcinogenesis: a review of mechanisms PDF
Kanwal Tariq, Kulsoom Ghias 120-135

Original Article

Establishment and application of a multiplex genetic mutation-detection method of lung cancer based on MassARRAY platform PDF
Hong-Xia Tian, Xu-Chao Zhang, Zhen Wang, Jian-Guang Chen, Shi-Liang Chen, Wei-Bang Guo, Yi-Long Wu 68-76
Second-line panitumumab as a triweekly dose for patients with wild-type KRAS exon 2 metastatic colorectal cancer: a single-institution experience PDF
Mohamed A. Daoud, Engy M. Aboelnaga, Wael M. Mohamed 136-141
Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery? PDF
Hai-Fei Niu, Li-Juan Wei, Jin-Pu Yu, Zhen Lian, Jing Zhao, Zi-Zheng Wu, Jun-Tian Liu 142-149

Meeting Report

Advances in caring for the older cancer patient: a report from the 2015 conference of the International Society of Geriatric Oncology PDF
Rob Stepney 150-155


OUR FRIENDS